These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23407560)

  • 1. Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC?
    Sacher AG; Le LW; Leighl NB; Coate LE
    J Thorac Oncol; 2013 Mar; 8(3):366-8. PubMed ID: 23407560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced non-small cell lung cancer in the elderly.
    Sequist LV; Fidias P
    Semin Respir Crit Care Med; 2005 Jun; 26(3):289-97. PubMed ID: 16052430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.
    Gentzler RD; Yentz SE; Johnson ML; Rademaker AW; Patel JD
    Cancer; 2014 Dec; 120(24):3853-8. PubMed ID: 25155290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of ongoing clinical trials in non-small-cell lung cancer: a status report for 2012 from the ClinicalTrials.gov Web site.
    Subramanian J; Regenbogen T; Nagaraj G; Lane A; Devarakonda S; Zhou G; Govindan R
    J Thorac Oncol; 2013 Jul; 8(7):860-5. PubMed ID: 23478543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.
    Hotta K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    Lung Cancer; 2004 Oct; 46(1):61-76. PubMed ID: 15364134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
    Weiss GJ; Langer C; Rosell R; Hanna N; Shepherd F; Einhorn LH; Nguyen B; Paul S; McAndrews P; Bunn PA; Kelly K
    J Clin Oncol; 2006 Sep; 24(27):4405-11. PubMed ID: 16983108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for stage III non-small-cell lung carcinoma in the elderly (age ≥ 70 years).
    Aridgides PD; Janik A; Bogart JA; Duffy S; Rosenbaum P; Gajra A
    Clin Lung Cancer; 2013 Nov; 14(6):674-9. PubMed ID: 23891240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced non-small-cell lung cancer in the elderly.
    Gridelli C; Maione P; Rossi A; Ferrara ML; Castaldo V; Palazzolo G; Mazzeo N
    Lung Cancer; 2009 Dec; 66(3):282-6. PubMed ID: 19879012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer.
    Coate LE; Massey C; Hope A; Sacher A; Barrett K; Pierre A; Leighl N; Brade A; de Perrot M; Waddell T; Liu G; Feld R; Burkes R; Cho BC; Darling G; Sun A; Keshavjee S; Bezjak A; Shepherd FA
    J Thorac Oncol; 2011 Mar; 6(3):537-44. PubMed ID: 21258243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.
    Jatoi A; Hillman S; Stella P; Green E; Adjei A; Nair S; Perez E; Amin B; Schild SE; Castillo R; Jett JR;
    J Clin Oncol; 2005 Dec; 23(36):9113-9. PubMed ID: 16361618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non–small-cell lung cancer in elderly patients: a discussion of treatment options.
    Gajra A; Jatoi A
    J Clin Oncol; 2014 Aug; 32(24):2562-9. PubMed ID: 25071101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.
    Al-Shamsi HO; Al Farsi A; Ellis PM
    Clin Lung Cancer; 2014 Jul; 15(4):274-80. PubMed ID: 24685356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
    Berghmans T; Tragas G; Sculier JP
    Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
    Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
    Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of ongoing clinical trials in non-small cell lung cancer: a status report for 2009 from the ClinicalTrials.gov website.
    Subramanian J; Madadi AR; Dandona M; Williams K; Morgensztern D; Govindan R
    J Thorac Oncol; 2010 Aug; 5(8):1116-9. PubMed ID: 20592626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of advanced non-small-cell lung cancer in elderly patients].
    Miyauchi E; Inoue A
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):6-11. PubMed ID: 25596674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer?
    Shanafelt TD; Loprinzi C; Marks R; Novotny P; Sloan J
    J Clin Oncol; 2004 May; 22(10):1966-74. PubMed ID: 15111619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.